Cybersight AI

by Orbis International  · Based in United States → — Transform ophthalmology with Cybersight AI. This clinical decision support tool uses artificial intelligence to detect diabetic retinopathy and glaucoma, revolutionizing screening and referral processes.
Endocrinology Family Medicine Ophthalmology

Free
Regulatory Status Disclosed

Overview

Cybersight AI is a clinical decision support tool for ophthalmology developed and maintained in-house by Orbis International. It utilizes artificial intelligence to detect diabetic retinopathy, glaucoma, and other conditions from fundus images. The tool is exclusively available in low- and middle-income countries (LMICs) at no cost to end-users. Cybersight AI aims to reduce screening and referral decision times from days or weeks to minutes, enable non-medical staff to perform screenings, and increase patient referral compliance. A randomized control trial in Rwanda showed that patients receiving immediate referral advice from Cybersight AI were 30% more likely to follow through with their referral. The platform also offers “Machine Mentoring,” which provides on-screen annotation and quantification of biomarkers and pathologies to educate healthcare providers. Cybersight AI is camera-agnostic, meaning it can be used with any high-quality fundus camera. It is available in two versions: Occasional Use via the Cybersight Consult Mobile app for results in one minute with a standard PDF report, and High Volume Screening for DR screening programs with results in five seconds and customized reports.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection of diabetic retinopathy, glaucoma, and other eye conditions from fundus images
  • Speed and efficiency: reduces screening and referral decision time to minutes
  • Task shifting: enables non-medical staff (nurses, technicians, community health workers) to perform screenings
  • Increased referral compliance: clinical trials show 30% higher follow-through with immediate referral advice
  • Machine Mentoring: on-screen annotation and quantification of biomarkers and pathologies for educational purposes
  • Camera-agnostic: compatible with any high-quality fundus camera
  • Two versions: Occasional Use (mobile app, 1-minute results) and High Volume Screening (DR programs, 5-second results)
  • Customized reports and protocols for high-volume screening
  • Integration with Cybersight Consult for AI-only cases or second opinions with human mentors
  • Data encryption in transit and storage, industry-standard security features

Use Cases

  • Diabetic retinopathy screening programs in low- and middle-income countries
  • Early detection of glaucoma and macular disease
  • Clinical decision support for ophthalmology
  • Training and education for eye health professionals (Machine Mentoring)
  • Improving access to eye care in underserved regions
  • Supporting remote mentorship and telemedicine consultations

What Physicians Need to Know

Evidence Base
Cybersight AI is a clinical decision support tool for ophthalmology. It can detect diabetic retinopathy, glaucoma and other conditions from fundus images. Evidence includes studies on feasibility and acceptance of AI-based diabetic retinopathy screening in Rwanda, impact of AI assessment of diabetic retinopathy on referral service uptake, and detection of diabetic retinopathy in the elderly in Vietnam.
Clinical Validation Studies
A Randomized Control Trial in Rwanda showed the sensitivity of Cybersight AI for referable DR was 92% (95% CI 0.863%, 0.968%), with a specificity of 85% (95% CI 0.751%, 0.882%).
Differential Diagnosis Support
Provides on-screen annotation and quantification of biomarkers and other pathologies for conditions like diabetic retinopathy and glaucoma.
Clinical Workflow Integration
Designed for speed and efficiency, reducing screening and referral decision time to minutes. Supports task shifting, allowing non-medical staff to be trained for screening. Offers two versions: Occasional Use (results in 1 minute, standard PDF report) and High Volume Screening (results in 5 seconds, customized reports & protocols).
Decision Audit Trail
Users of Cybersight AI only have access to data in workspaces they have been granted access to (i.e. their own patients). A limited amount of data is collected about patients. By default, all Cybersight AI records are anonymous. Implementers may optionally choose to collect a patient identifier.
Physician Tip

Cybersight AI can significantly reduce the time for screening and referral decisions for ophthalmological conditions. Its 'Machine Mentoring' feature with on-screen annotations can aid in learning and understanding biomarker quantification. The tool is camera-agnostic, allowing use with various high-quality fundus cameras. It is particularly beneficial in low- and middle-income countries due to its no-cost availability and ability to support task shifting to non-medical staff.

Cybersight AI is camera-agnostic and can be used with any high-quality fundus camera. The high-volume screening version supports both desktop and handheld cameras. It requires an internet connection for operation. It integrates with Cybersight Consult for AI-only case creation and PDF reports.

Details

Category Clinical Decision Support & Reference, Ophthalmology AI
Pricing Free
DeploymentCloud-based
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Not applicable AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Ophthalmology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cybersight AI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Cybersight AI.

View all on YouTube

Frequently Asked Questions

Cybersight AI is a clinical decision support tool for ophthalmology that can detect diabetic retinopathy, glaucoma, and other conditions from fundus images.
Cybersight AI is available exclusively in low- and middle-income countries for eye health professionals, including technicians, nurses, optometrists, and ophthalmologists.
No, Cybersight AI is camera-agnostic and can be used with any high-quality fundus camera.
There are two versions: 'Occasional Use' via the Cybersight Consult Mobile app for results in 1 minute, and 'High Volume Screening' for DR screening programs with results in 5 seconds.
No, Cybersight AI requires an internet connection to operate.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-26 | First Added: 2026-07-26
AI Tool Finder
AI-powered search. Results may not be comprehensive.